Cary, NC, United States of America

Greg Alan Erickson


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Greg Alan Erickson: A Look into His Patent and Career.

Introduction

Greg Alan Erickson, an inventor based in Cary, North Carolina, has made notable contributions to the field of pharmaceuticals. With one patent to his name, Greg has demonstrated his expertise and commitment to advancing innovative solutions in medicine.

Latest Patents

Greg’s patent, which focuses on “Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma,” describes a complex compound formula that presents various structural options. This invention plays a significant role in potentially influencing PPAR-gamma activity, which is essential in various therapeutic applications. The specific components of the invention involve various groups that enhace its utility in medicinal chemistry.

Career Highlights

Currently employed at Glaxo Wellcome Inc., Greg has established a reputable career in the pharmaceutical industry. His work involves collaborative efforts aimed at developing new therapeutic agents and innovative pharmaceuticals that meet the evolving needs of healthcare.

Collaborations

Throughout his career, Greg has collaborated with notable professionals in the industry, including Timothy Mark Willson. These partnerships reflect a commitment to excellence and innovation in the development of new compounds and medical solutions.

Conclusion

In summary, Greg Alan Erickson’s contributions to innovation within the pharmaceutical field stand as a testament to his dedication as an inventor. With his patent and involvement at Glaxo Wellcome Inc., Greg continues to pave the way for advancements that benefit the medical community and patients alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…